Age Verification

This site contains research compounds intended for laboratory use only.

You must be 21 years or older to enter.

By continuing you confirm you are of legal age and understand these products are not for human consumption.

Research Library

Research use only. For laboratory research use only. Not for human consumption. This summary describes published research and is not medical advice.

Plain-language summaries of the published research on each compound we carry, with links to every source. The summaries describe what studies reported, what kind of study it was (human, animal or cell), and where the evidence is thin.

How the library was built

Compounds

*Human RCT counts include ClinicalTrials.gov entries with randomized allocation. Total human-study records across the catalog: 304 randomized, 320 other.

BPC-157

243 catalogued records

Mostly rat injury-model studies; three small uncontrolled human pilots.

  • 3 human RCT*
  • 8 human other
  • 156 animal
  • 3 in vitro
  • 55 reviews
  • 4 registered trials
Read the summary

TB-500 / Thymosin β4

332 catalogued records

Clinical trials of full-length Tβ4; no human trials of the TB-500 fragment.

  • 28 human RCT*
  • 69 human other
  • 117 animal
  • 17 in vitro
  • 80 reviews
  • 20 registered trials
Read the summary

Wolverine (BPC-157 + TB-500)

14 catalogued records

One rat study of the combination; the rest are reviews.

  • 0 human RCT*
  • 2 human other
  • 1 animal
  • 0 in vitro
  • 10 reviews
  • 0 registered trials
Read the summary

GHK-Cu

226 catalogued records

Topical human studies; rodent and cell wound-healing work.

  • 4 human RCT*
  • 15 human other
  • 76 animal
  • 33 in vitro
  • 19 reviews
  • 2 registered trials
Read the summary

Retatrutide

249 catalogued records

Large phase 2 and phase 3 randomized trials; investigational.

  • 40 human RCT*
  • 24 human other
  • 19 animal
  • 1 in vitro
  • 131 reviews
  • 34 registered trials
Read the summary

MOTS-c

274 catalogued records

Mouse studies; human records measure the body’s own MOTS-c.

  • 5 human RCT*
  • 53 human other
  • 109 animal
  • 5 in vitro
  • 56 reviews
  • 3 registered trials
Read the summary

Tesamorelin

114 catalogued records

Phase 3 randomized trials behind an FDA-approved indication.

  • 38 human RCT*
  • 23 human other
  • 5 animal
  • 1 in vitro
  • 28 reviews
  • 21 registered trials
Read the summary

CJC-1295 + Ipamorelin

78 catalogued records

Phase 1–2 data for each compound; no combination studies.

  • 6 human RCT*
  • 2 human other
  • 31 animal
  • 3 in vitro
  • 12 reviews
  • 3 registered trials
Read the summary

Semax

211 catalogued records

Mostly Russian animal studies; small Russian clinical series.

  • 1 human RCT*
  • 20 human other
  • 155 animal
  • 6 in vitro
  • 12 reviews
  • 0 registered trials
Read the summary

Selank

68 catalogued records

Russian rodent studies; a handful of small Russian clinical series.

  • 2 human RCT*
  • 4 human other
  • 54 animal
  • 0 in vitro
  • 2 reviews
  • 0 registered trials
Read the summary

NAD+

398 catalogued records

Mostly precursor (NR/NMN) trials; few studies of direct NAD+.

  • 177 human RCT*
  • 100 human other
  • 55 animal
  • 2 in vitro
  • 60 reviews
  • 207 registered trials
Read the summary

GLOW (BPC-157 + TB-500 + GHK-Cu)

6 catalogued records

No primary studies of the combination; six review articles.

  • 0 human RCT*
  • 0 human other
  • 0 animal
  • 0 in vitro
  • 6 reviews
  • 0 registered trials
Read the summary
Research use only. For laboratory research use only. Not for human consumption. This summary describes published research and is not medical advice.